Table 2.
Acute coronary syndrome characteristics.
| Overall (N = 73) | Lymphoid (N = 29) | Myeloid (N = 44) | |
|---|---|---|---|
| Presentation characteristics | |||
| Type of ACS | |||
| Unstable angina, n (%) | 6 (8.2) | 5 (17.2) | 1 (2.3)* |
| NSTEMI, n (%) | 57 (78.1) | 19 (65.5) | 38 (86.4)* |
| STEMI, n (%) | 10 (13.7) | 5 (17.2) | 5 (11.4) |
| Presenting symptoms | |||
| Asymptomatic, n (%) | 7 (9.6) | 5 (17.2) | 2 (4.5) |
| Chest pain, n (%) | 38 (52.1) | 14 (48.3) | 24 (54.5) |
| Dyspnea, n (%) | 20 (27.4) | 4 (13.8) | 16 (36.4)* |
| Heart failure, n (%) | 16 (21.9) | 6 (20.7) | 10 (22.7) |
| Hypotension, n (%) | 4 (5.5) | 3 (10.3) | 1 (2.3) |
| Others, n (%) | 10 (13.7) | 6 (20.7) | 4 (9.1) |
| Laboratory parameters | |||
| Hemoglobin, g/dL | 9.4 ± 1.7 | 10.2 ± 1.7 | 8.8 ± 1.5* |
| WBC count, /μL | 25,200 ± 50,200 | 13,400 ± 16,400 | 33,100 ± 62,300 |
| Platelet count, /μL | 117,500 ± 158,200 | 121,100 ± 91,600 | 115,100 ± 190,920 |
| Creatinine, mg/dL | 1.2 ± 0.6 | 1.1 ± 0.5 | 1.2 ± 0.6 |
| Peak troponin T (ng/mL) | 0.58 ± 1.01 | 0.44 ± 0.68 | 0.68 ± 1.18 |
| Post ACS ejection fraction, % | 49.3 ± 15.2 | 50.3 ± 13.2 | 48.6 ± 16.3 |
| Management characteristics | |||
| Medical, n (%) | 55 (75.3) | 18 (62.1) | 37 (84.1)* |
| Unstable angina, n (%) | 2 (3.6) | 1 (5.6) | 1 (2.7) |
| NSTEMI, n (%) | 47 (64.4) | 14 (77.8) | 33 (89.2) |
| STEMI, n (%) | 6 (10.9) | 3 (16.7) | 3 (8.1) |
| Invasive, n (%) | 18 (24.7) | 11 (37.9) | 7 (15.9)* |
| Unstable angina, n (%) | 4 (22.2) | 4 (36.4) | 0 (0) |
| PCI, n (%) | 4 (100) | 4 (100) | – |
| NSTEMI, n (%) | 10 (55.6) | 5 (45.5) | 5 (71.4) |
| PCI, n (%) | 3 (30.0) | 2 (40.0) | 1 (25.0) |
| STEMI, n (%) | 4 (22.2) | 2 (18.2) | 2 (28.6) |
| PCI, n (%) | 3 (75.0) | 1 (50.0) | 2 (100) |
| Coronary angiography | 18 (24.7) | 11 (37.9) | 7 (15.9)* |
| Type 1 MI | 6 (33.3) | 3 (27.3) | 3 (42.9) |
| Type 2 MI | 12 (66.7) | 8 (72.7) | 4 (57.1) |
| Medications | |||
| Aspirin, n (%) | 40 (54.8) | 19 (65.5) | 21 (47.7) |
| P2Y12RI, n (%) | 15 (20.5) | 9 (31.0) | 6 (13.6) |
| Heparin, n (%) | 31 (42.5) | 17 (58.6) | 14 (31.8)* |
| Beta-blockers, n (%) | 62 (84.9) | 25 (86.2) | 37 (84.1) |
| ACEI/ARB, n (%) | 24 (32.9) | 10 (34.5) | 14 (31.8) |
| Statin, n (%) | 42 (57.5) | 18 (62.1) | 24 (54.5) |
*
p < 0.05 for myeloid vs. lymphoid.